SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.83-0.7%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mudcat who wrote (24448)8/13/1998 1:47:00 PM
From: Machaon  Read Replies (1) of 32384
 
<< The $1B figure is misleading as are most of your posts. >>

I love you too.

<< The $1B is for drugs with large clinical populations >>

Oh. I'm sorry. I thought that I made it very, extremely clear, that the $1 billion was an average of all drugs, successes or failures.

You are totally wrong on this point. If you take ALL of the drugs, those that passed FDA approval, and those that failed, you get an average cost of $1 billion dollars. Why was that so misleading to you?

I admit that SRGN didn't spend $1 billion on ONTAK. But, isn't it interesting that so many billions are spent just to get a few drugs approved?

Hmmmmmm!? I've got to either accept your opinion that Ligand spend 16 "wasted" months of research and negotiations trying to buy SRGN, or accept Ligand's management's intentions as buying a good value.

Hmmmm!? Who has better credibility, Ligand's management, or a Mudrat?

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext